In regard to Novel and Elite's history with VGS and Dr

New Post Public Reply Private Reply Replies (2) Message Board
Couch tangerine #349

In regard to Novel and Elite's history with VGS and Dr VS.....it has always been a little murky in terms of the 2 million dollars VGS invested in Elite....and how Elite ended up originally with 49% of Novel. I'm assuming that VGS ended up with preferred shares of Elite.....did Elite then take that $2 million dollars and invest it in forming Novel? A bit confusing the details here......Should be interesting to see how Elite's stake in Novel pans out.

Elite Pharmaceuticals Press Release for: Wednesday, December 13, 2006



Elite Pharmaceuticals Appoints a Prominent Specialty Pharmaceutical Executive, Dr. Veerappan Subramanian, to its Board of Directors and Engages Dr. Subramanian as Strategic Advisor

Elite Receives $2 Million Equity Investment

Elite Forms Novel Laboratories Focused on Specialty Generic Pharmaceutical Products

-- Conference Call to be Held on December 13 at 11:00am EST --



Northvale, New Jersey, Wednesday, December 13, 2006: Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (AMEX: ELI) has commenced a Strategic Alliance with Dr. Veerappan Subramanian under which Dr. Subramanian has joined Elite’s Board of Directors and will serve as strategic advisor to Elite on the research, development and commercialization of Elite’s existing pipeline, including its two lead pain products. As part of the Strategic Alliance with Elite, VGS Pharma LLC has made a $2 million equity investment in Elite. 

Dr. Subramanian brings extensive experience in generics formulation and management, having been responsible for the development and FDA approval of over 150 specialty and generic drug products during his 33 years in the pharmaceutical industry. He was the founder and Chief Executive Officer of Kali Laboratories, Inc., a specialty generic pharmaceutical company, which was acquired by Par Pharmaceuticals in 2004 for consideration in excess of $135 million. Prior to Kali, Dr. Subramanian was the Vice President of Scientific Affairs for Zenith Laboratories, Inc., which was acquired by Ivax Corporation, in 1994, for approximately $600 million. 

As part of its Strategic Alliance with Dr. Subramanian, Novel Laboratories, Inc. was formed as a separate specialty pharmaceutical company for the research, development, manufacturing, licensing and acquisition of specialty generic pharmaceuticals. Novel Laboratories will utilize Dr. Subramanian’s expertise and established track record of building successful pharmaceutical companies and will develop a new portfolio of products, independent of Elite’s current pipeline. Dr. Subramanian will serve as Chief Executive Officer of Novel Laboratories, which is owned 49% by Elite and 51% by VGS Pharma LLC, a company controlled by Kali Management, LLC. The Board of Directors of Novel Laboratories shall consist of two directors with Elite and VGS Pharma having the right to name one of the two directors. 

“This Strategic Alliance provides Elite with a rare opportunity to join forces with a highly accomplished formulator and experienced business executive in the generic pharmaceutical industry. As the Chief Executive Officer of Novel, Dr. Subramanian will oversee the development and commercialization of Novel’s generic and specialty drug pipeline. In addition, we look forward to Dr. Subramanian’s service on Elite’s board and his strategic advice in support of Elite’s existing product pipeline. This will enable Elite to enhance its focus on its abuse resistant and controlled release opioid pain products, while maintaining a strong presence in the specialty generic drug industry through its interest in Novel,” said Bernard Berk, Chairman and CEO of Elite Pharmaceuticals. 

“I look forward to the challenges of building a new company in the current dynamic global generic pharmaceutical environment and assisting Elite on its continued development of specialty pharmaceutical products in the therapeutic area of pain management. Elite’s technology and its state of the art facility are well suited for the development and manufacturing of the novel opioid drugs currently under development by the Company. I am excited to join forces with Buddy Berk, a seasoned pharmaceutical executive, in building Novel Laboratories, a new research-based specialty pharmaceutical company,” said Veerappan Subramanian, Ph.D., Chairman and CEO of Novel Laboratories, Inc.

Elite Pharmaceuticals Inc (ELTP) Stock Research Links

ELTP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swim Readiness Depends on Skills, Not Birthdays Alone

Updated Category News Views 34

A child popping up calmly after a brief dunk tells you more than a birthday ever will. That is the sensible center of Woody Alpern's guidance for families weighing whether a child belongs in the next swim level. The Atlanta swim school expert's point is refreshingly free of the usual parental race: advancement is earned through repeatable skills, comfort, and judgment in...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 48

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
Korla Kiln Gains Show How Cement Efficiency Is Won

Updated Category News Views 79

A cement kiln does not care about corporate slogans; it cares whether the flame holds, the bearings stay alive, and the feed keeps moving. That is why the work at Xinjiang Tianshan Cement's Tashidian branch in Korla deserves a closer look. This is not a glossy tale about a futuristic factory appearing overnight. It is an account of an old, unforgiving industrial process...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 85

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 37

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
YYForce Security Win Adds Recurring Singapore Revenue Base

Updated Category News Views 124

A retail-property security mandate rarely makes anyone pound the table, and frankly it should not. Still, YYForce has landed a tangible two-year contract in Singapore worth roughly S$831,120, with subsidiary Uniforce Security Services set to begin work on December 1, 2026. For NASDAQ:YFOR investors, this is the kind of small, operationally real win that deserves a sober...

Continue Reading
Danaher and Microsoft Put AI Into the Lab Stack Early

Updated Category News Views 60

Laboratory AI gets interesting only when it reaches the hardware bench, and Danaher is taking a serious swing at that ugly, complicated job with Microsoft. The Nov. 20 partnership is not just another chatbot bolted onto a dashboard. It is aimed at building a common agentic platform that can help instruments interpret scientific intent, guide setup, control hardware within...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 15

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 83

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
Millrose Lawsuit Puts Disclosure Discipline in Focus

Updated Category News Views 15

A supposedly clean homesite-option story has wandered into the legal weeds, and that is exactly where investors need to slow down. A shareholder class action against Millrose Properties alleges the company painted one business model for the market while pursuing a materially different one behind the curtain. That allegation has not been proven in court, and anybody...

Continue Reading

Top 5 Most Recently Viewed Articles

LootBar Enhances Game Recharge with New Security Features

Updated Category News Views 193

LootBar Redefines Game Recharge Security As players seek a secure method for discounted game top-ups, LootBar has introduced a groundbreaking self top-up feature. This innovative addition empowers gamers to conduct transactions without exposing their account passwords, presenting a safer alternative to traditional recharge methods. A Major Leap Forward in Security The...

Continue Reading
Marriott Bonvoy Unveils Unique Pet-Friendly Travel Program

Updated Category News Views 406

Introduction to the Pawssible Journey Program Marriott Bonvoy, a beloved travel program from Marriott International, is set to enchant pet owners across Greater China with the introduction of its new initiative called the "Pawssible Journey." This innovative program is founded on three primary experiences: "Paw Stay" themed accommodations, "Paw Play" social interaction...

Continue Reading
Xeriant Unveils Groundbreaking Video Showcasing Fire Safety Innovation

Updated Category News Views 155

Xeriant Highlights Innovative Fire-Retardant Technology in New Video Xeriant, Inc. (OTCQB: XERI), a pioneering company dedicated to the discovery and commercialization of advanced materials technology, has released a fascinating video that dives into the remarkable performance of their nanotech fire-retardant. This video encapsulates the power of their innovative fire...

Continue Reading
Understanding Blackstone's Recent Options Activity and Trends

Updated Category News Views 202

Blackstone's Bullish Options Environment Investors looking at Blackstone are seeing some exciting movements in the options market. These activities have been driven by significant investment interest, hinting that major players are optimistic about Blackstone's future. Insight into Trading Patterns Upon reviewing the trading history for Blackstone (NYSE: BX), multiple...

Continue Reading
Top Smart Meter Startups Spotlight: 360Quadrants Key Report

Updated Category News Views 306

360Quadrants Highlights Smart Meter Startups in 2025 360Quadrants has recently unveiled an insightful report that shines a light on the leading startups and SMEs in the smart meter industry. This comprehensive evaluation showcases both established global players and emerging innovators who are making remarkable strides in market presence, product development, and...

Continue Reading